Early diagnosis of CF can be achieved through a combination of newborn screening, sweat testing, and genetic testing. Newborn screening typically involves a blood test to check for elevated levels of immunoreactive trypsinogen (IRT), a marker for CF. If the IRT levels are high, further diagnostic tests such as a sweat chloride test and genetic testing for CFTR mutations are conducted.
